Skip to main content

Table 1 Multivariate logistic regression analysis of treatment choice in patients with incurable cancer

From: Impact of palliative chemotherapy and best supportive care on overall survival and length of hospitalization in patients with incurable Cancer: a 4-year single institution experience in Japan

Variable

Palliative chemotherapy

BSC

 

OR (95%CI)

P-value

101 (78.3%)

28(21.7%)

129

  

Type of cancer

 Gastric ca.

46 (83.6%)

9 (16.4%)

55

18.88 (1.59–224.59)

< 0.05*

 Colon ca.

32 (86.5%)

5 (13.5%)

37

21.99 (1.74–277.45)

< 0.05*

 Esophageal ca.

13 (76.5%)

4 (23.5%)

17

13.55 (0.95–192.92)

0.054

 MMT

9 (69.2%)

4 (30.8%)

13

5.83 (0.41–83.02)

0.193

 CUP

1 (14.3%)

6 (85.7%)

7

1.00 (ref.)

 

Sex

 Female

28 (73.7%)

10 (26.3%)

38

0.53 (0.18–1.53)

0.237

 Male

73 (80.2%)

18 (19.8%)

91

1.00 (ref.)

 

Age(years)

  ≤ 70

62 (84.9%)

11 (15.1%)

73

3.32 (1.16–9.54)

< 0.05*

  > 70

39 (69.6%)

17 (30.4%)

56

1.00 (ref.)

 

ECOG PS

 0–2

91 (84.3%)

17 (15.7%)

108

4.99 (1.52–16.42)

< 0.01*

 3–4

10 (47.6%)

11 (52.4%)

21

1.00 (ref.)

 
  1. *P < 0.05
  2. Abbreviations: BSC best supportive care, CI confidence interval, CUP carcinoma of unknown primary, ECOG Eastern Cooperative Oncology Group, MMT miscellaneous malignant tumor, OR odds ratio, PS performance status, ref reference